|
Volumn 39, Issue 6, 2007, Pages 1936-1938
|
Liver Transplantation in HIV-Positive Patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
EFAVIRENZ;
IMMUNOSUPPRESSIVE AGENT;
LAMIVUDINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PEGINTERFERON;
RIBAVIRIN;
STEROID;
TACROLIMUS;
VIRUS RNA;
ZIDOVUDINE;
ADULT;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
FEASIBILITY STUDY;
FEMALE;
FOLLOW UP;
HEPATITIS B VIRUS;
HEPATITIS C;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
LIVER CELL CARCINOMA;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MALE;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
RECURRENT INFECTION;
SUPERINFECTION;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
ADULT;
GRAFT REJECTION;
HIV INFECTIONS;
HIV SERONEGATIVITY;
HIV-1;
HUMANS;
INCIDENCE;
LIVER FAILURE;
LIVER TRANSPLANTATION;
PATIENT SELECTION;
RETROSPECTIVE STUDIES;
RNA, VIRAL;
SURVIVAL ANALYSIS;
|
EID: 34547598102
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2007.05.076 Document Type: Article |
Times cited : (31)
|
References (7)
|